Butyric acid, a gut bacteria metabolite, lowers arterial blood pressure via colon-vagus nerve signaling and GPR41/43 receptors

Abstract

Butyric acid (BA) is a short-chain fatty acid (SCFA) produced by gut bacteria in the colon. We hypothesized that colon-derived BA may affect hemodynamics. Arterial blood pressure (BP) and heart rate (HR) were recorded in anesthetized, male, 14-week-old Wistar rats. A vehicle, BA, or 3-hydroxybutyrate, an antagonist of SCFA receptors GPR41/43 (ANT) were administered intravenously (IV) or into the colon (IC). Reactivity of mesenteric (MA) and gracilis muscle (GMA) arteries was tested ex vivo. The concentration of BA in stools, urine, portal, and systemic blood was measured with liquid chromatography coupled with mass spectrometry. BA administered IV decreased BP with no significant effect on HR. The ANT reduced, whereas L-NAME, a nitric oxide synthase inhibitor, did not affect the hypotensive effect of BA. In comparison to BA administered intravenously, BA administered into the colon produced a significantly longer decrease in BP and a decrease in HR, which was associated with a 2–3-fold increase in BA colon content. Subphrenic vagotomy and IC pretreatment with the ANT significantly reduced the hypotensive effect. Ex vivo, BA dilated MA and GMA. In conclusion, an increase in the concentration of BA in the colon produces a significant hypotensive effect which depends on the afferent colonic vagus nerve signaling and GPR41/43 receptors. BA seems to be one of mediators between gut microbiota and the circulatory system.Electronic supplementary materialThe online version of this article (10.1007/s00424-019-02322-y) contains supplementary material, which is available to authorized users.

Faster Short-Chain Fatty Acid Absorption from the Cecum Following Polydextrose Ingestion Increases the Salivary Immunoglobulin A Flow Rate in Rats

“…The Bayesian network analysis showed that the salivary IgA flow rate, normalized on the submandibular gland tissue weight, was directly affected by the SCFA concentration in portal vein blood ( Figure 5 ). Reportedly, blood SCFA levels are sufficient to activate G-protein-coupled receptors (GPR) 41 and GPR43, to trigger autonomic nerve stimulation [ 39 , 40 , 41 ]. In addition, Carpenter et al predicted that autonomic nerve stimulation would significantly elevate salivary IgA levels [ 42 , 43 ].…”

Gut Microbiota in Hypertension and Atherosclerosis: A Review

“…Animal studies showed that higher colonic levels of acetate could result in blood pressure lowering through parasympathetic activation. In addition, the blood pressure lowering effects of butyrate in rats were shown to be significantly reduced by vagotomy [ 67 ]. Another study with spontaneous hypertensive rats described a reduced central responsiveness to butyrate, as a result from reduced expression of butyrate receptors in the hypothalamus [ 52 ].…”

Acetate, a Short-Chain Fatty Acid, Acutely Lowers Heart Rate and Cardiac Contractility Along with Blood Pressure

“…SCFAs induce vasodilation in blood vessels ex vivo and hypotension in vivo (Keshaviah, 1982;Daugirdas and Nawab, 1987;Mortensen et al, 1990;Natarajan et al, 2016;Onyszkiewicz et al, 2019). Acute administration of SCFAs lowers blood pressure, and this effect is mediated in part by G protein-coupled receptors such as Olfr78 and GPR41 (Pluznick et al, 2013;Natarajan et al, 2016;Onyszkiewicz et al, 2019).…”